用secukinumab管理麻风反应:从一系列病例中的见解
Luciana Vilela Gomide1,2, João Paulo Turri Brufatto1, Thiago Jessé Kucarz1
1Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP, Brasil.
Revista da Sociedade Brasileira de Medicina Tropical
|October 2, 2025
概括
塞库金纽马布在治疗炎症性疾病 - - 红斑结节 (ENL) 方面表现有前途. 这种治疗可能会减少ENL发作,并减少皮质类固醇的使用.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 类风湿病学 类风湿病学
背景情况:
- 红斑结节 (ENL) 是一种免疫媒介的炎症状况,需要有效的管理.
- 耐火性ENL病例由于治疗耐药性和标准疗法的不良影响而带来挑战.
- 临床上需要对ENL进行替代治疗选择.
研究的目的:
- 评估secukinumab作为Erythema nodosum leprosum治疗的疗效和安全性. 为了评估secukinumab作为Erythema nodosum leprosum治疗的疗效和安全性.
- 评估secukinumab在ENL管理中的皮质类固醇节约潜力.
主要方法:
- 进行了一项回顾性研究,涉及5名被诊断患有ENL的患者.
- 患者在2023年1月至2025年1月期间接受了secukinumab治疗.
主要成果:
- 在患有ENL的患者中,secukinumab治疗导致了显著的临床改善.
- 观察到的好处包括减少ENL发作的频率和缓解神经炎.
- 患者体验到皮质类固醇需求的减少.
结论:
- 塞库金纽马布为红斑结节的治疗提供了潜在的皮质类固醇节约治疗选择.
- 这种治疗在研究的队列中表现出了有利的安全性.
- 需要进一步的研究来验证secukinumab对ENL的长期疗效和安全性.
相关概念视频
01:26Nephrotic Syndrome II : Assessment and Medical Management
201
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
201
01:24Nephrotic Syndrome III : Nursing Management
282
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
282